基因检测公司富尔金特基因（Fulgent Genetics）今日盘前大涨9.20%，引发市场关注。该公司股价的强劲表现主要源于其最新发布的财务预期和季度业绩报告。
富尔金特基因宣布上调2025财年的营收预期至3.25亿美元，高于此前预期的3.2亿美元。这一调整超过了分析师平均预期的3.2012亿美元。同时，公司公布的第三季度营收为8407万美元，远超市场预期的8140万美元。这些积极的财务数据显示了公司业务的强劲增长势头。
值得注意的是，富尔金特基因的股价在此次上涨前已经累计上涨20.8%。此次盘前大涨进一步凸显了投资者对公司未来发展前景的信心。随着基因检测技术在医疗健康领域的应用不断扩大，富尔金特基因有望继续受益于行业增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.